Black Diamond Therapeutics, Inc. ( BDTX ) has been something of a diamond in the rough, at least if you looked at it earlier in 2025. In my last coverage of the companyI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosure: ...